EICHORCondition: Iodine Deficiency · Sponsor: EUthyroid
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
In the EUthyroid2 intervention, measures are being developed and implemented in educational settings across the UK, Germany, Slovenia, the Republic of Cyprus, Bangladesh, and Pakistan to effectively raise awareness of the risks associated with iodine deficiency. Each participating country will employ three measurement points. The intervention will be tailored to the specific contextual characteristics of each implementation site. A process evaluation utilizing a convergent parallel mixed methods design will be conducted, involving surveys of students and teachers, as well as semi-structured interviews.
This description comes directly from the study's public registry record.
Henry Völzke · 0049 3834 86 75 41 · henry.voelzke@med.uni-greifswald.de
Always discuss trial participation with your own doctor first.
| Bangladesh University of Health | Dhaka, Bangladesh | Recruiting |
| Cyprus University of Technology | Limassol, Cyprus | Recruiting |
| University Medicine Greifswald | Greifswald, Germany | Recruiting |
| Islamia College Peshawar | Peshawar, Khyber Pakhtunkhwa, Pakistan | Recruiting |
| University Medical Centre Ljubljana | Ljubljana, Slovenia | Recruiting |
| University of Surrey; Queen's University Belfast | Guildford, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06801691